315 Turnpike St
North Andover, MA 01845
United States
Merrimack College - Girard School of Business - Department of Accounting and Finance
SSRN RANKINGS
in Total Papers Citations
Financial Technology, Financial Innovation, Patents, Data Breach
Corporate Lobbying, CEO Political Ideology, Corporate Governance, Agency Problem, Excess Returns
Corporate lobbying, CEO political ideology, Corporate governance, Agency problem, Excess returns
corporate lobbying, corporate fraud, corporate governance
Corporate lobbying, corporate fraud, corporate governance
Corporate Lobbying, Corporate Fraud, Corporate Governance, Financial Institutions
green bonds, fixed income securities, certification, sustainable development
Corporate misconduct, Firm reputation, innovation
Institutional Investors; Litigation; Labor Relations; Firm Value
Institutional Investors, Labor Relations, Innovation
Innovation, Human Capital, Employee Treatment, Litigation
Mergers, acquisitions, Innovation, R&D, biotechnology
Islamic Banks, Basel I, Credit Risk, Market Risk, Operational Risk, Stress Testing, Scenario Analysis, Basel I, Capital Adequacy, Turkey
Innovation, R&D, biotechnology, life sciences, dividends, payout policy
Corporate Lobbying, Corporate Fraud, Corporate Governance, Regulation
CEO Reputation, Employee Relations, Corporate governance
corporate reputation and political economy, cybersecurity and data breach, financial fraud and violations, government subsidy awards, securities litigation
Lobbying, Employee relation, Employee litigation, Firm performance
Labor laws, litigation process, labor process
Litigation, Employee rights, Risk reduction, Firm performance, Labor force
Insider trading, Political lobbying, Firm performance
Corporate lobbying, FDA approval, Innovation, Government subsidy
Capital structure, Labor disputes, Employment protection, Employee lawsuit, Financial distress costs
Product recall, Market reaction, Stock valuation, Event study, Abnormal return
Institutional ownership, Firm innovation, Pharmaceuticals
Product Recall, Firm Value, FDA Approval